Find uplifting stories about heroes, innovations, and solutions
69 results for "lenacapavir"
Scientists discovered that when HIV develops resistance to the groundbreaking drug lenacapavir, the virus loses its ability to spread effectively. This finding offers hope that the twice-yearly injection can remain a powerful tool in preventing and treating HIV.
Scientists discovered that when HIV develops resistance to the breakthrough drug lenacapavir, the virus becomes significantly weaker and struggles to survive. This finding shows the medication is working even better than expected.
South Africa just became the ninth African nation to offer lenacapavir, a breakthrough HIV drug that requires only two injections per year instead of daily pills. The treatment could transform care for millions living with HIV, though access and supply questions remain.
Kenya just received its first shipment of Lenacapavir, a groundbreaking HIV prevention treatment that requires just two injections per year instead of daily pills. The new option could dramatically reduce infections among pregnant and breastfeeding women, who face the highest risk.
A twice-yearly injection called Lenacapavir prevented HIV transmission with near-perfect results across two major trials involving 8,200 people in high-risk areas. The breakthrough could transform HIV prevention by replacing daily pills with just two shots per year.
A new twice-yearly injection called lenacapavir prevents nearly all HIV infections and earned Science Magazine's 2024 Breakthrough of the Year. The discovery traces back to publicly funded research that started nearly 30 years ago.
A revolutionary HIV prevention drug requiring just two shots per year is rolling out across six Southern African countries. Lenacapavir provides over 99% protection against HIV in the region most affected by the epidemic.
South Africa just received its first shipment of Lenacapavir, a revolutionary HIV prevention injection that works for six months with a single dose. The breakthrough treatment could transform protection for vulnerable communities who struggle with daily prevention methods.
Kenya becomes the first country to roll out Lenacapavir, a groundbreaking injection that prevents HIV for six months with a single shot. The breakthrough could dramatically reduce the country's 20,000 annual new infections by eliminating daily pill routines.
South Africa just received 38,000 doses of a breakthrough HIV prevention injection that works for six months with just two shots per year. The country is the first in Africa to approve and roll out Lenacapavir, potentially transforming prevention for millions.
Clinics across South Africa began rolling out lenacapavir this week, a groundbreaking HIV prevention injection that requires just two shots per year and is over 96% effective. Despite some staffing challenges, patients are celebrating easier access to life-changing protection.
%2Ffile%2Fattachments%2Forphans%2FJab2_705866.jpg)
Starting June 5, half a million South Africans will have access to a breakthrough injection that prevents HIV for six months with nearly 100% effectiveness. This twice-yearly shot could finally turn the tide on a virus that still claims over 50,000 lives annually in the country.
A twice-yearly injection prevented every single HIV infection in a major clinical trial, offering new hope for Nigeria's 1.9 million people living with HIV. The challenge now is making this breakthrough affordable and accessible to those who need it most.
Kenya just became one of the first countries to offer a groundbreaking HIV prevention drug that requires just two injections per year, completely free to those who need it most. The move brings new hope to 1.4 million Kenyans living with HIV and vulnerable young people facing the highest risk of infection.
%2Ffile%2Fattachments%2Forphans%2FFEATUREIMAGE1_176820.jpg)
Starting April 1st, nearly half a million South Africans can access a groundbreaking HIV prevention injection that requires just two doses per year and has shown 100% effectiveness in trials. The free rollout could help end AIDS as a public health threat by 2043.
%2Ffile%2Fattachments%2Forphans%2FFeatureimage10July_KayleenMorgan_AssociatedPress1_504780.jpg)
A researcher's conversation with his aunt around a fire in rural Zambia revealed a critical gap between scientific breakthroughs and community understanding. His story shows why clear communication matters as much as medical innovation.
A twice-yearly shot prevents HIV with 100% effectiveness, but its $28,000 price tag keeps it out of reach. A proven "subscription pricing" model could make it accessible to everyone who needs it.
Kenya just became one of the first countries to offer a groundbreaking HIV prevention injection that protects people for six months with a single shot. The treatment is completely free and could change the lives of 1.4 million Kenyans living with HIV.
South Africa just became one of the first countries to roll out a revolutionary twice-yearly HIV prevention injection that could change the game for millions. After a decade of strategic planning, the nation is proving that bold public health leadership saves lives.
Uganda is expanding access to a groundbreaking HIV prevention injection that only needs to be taken twice a year, offering nearly 100% protection. The innovation could transform HIV prevention for thousands who struggle with daily medication.
Showing 20 of 69